Rhodomyrtone: A new candidate as natural antibacterial drug from Rhodomyrtus tomentosa

Phytomedicine

Volumn 16, Issue 6-7, 2009, Pages 645-651

  Limsuwan, Surasak ^a,b   Trip, Erik N ^c   Kouwen, Thijs R H M ^c   Piersma, Sjouke ^c   Hiranrat, Asadhawut ^d   Mahabusarakam, Wilawan ^d   Voravuthikunchai, Supayang P ^b,d   van Dijl, Jan Maarten ^c   Kayser, Oliver ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Faculty of Science   (Thailand)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Antibacterial activity; Antibiotic resistant bacteria; Medicinal plant; Methicillin resistant Staphylococcus aureus; Rhodomyrtone; Rhodomyrtus tomentosa

Indexed keywords

[6,8 DIHYDROXY 2,2,4,4 TETRAMETHYL 7 (3 METHYL 1 OXOBUTYL) 9 (2 METHYLPROPYL) 4,9 DIHYDRO 1H XANTHENE 1,3 (2H) DI ONE]; ANTIINFECTIVE AGENT; RHODOMYRTONE; UNCLASSIFIED DRUG; XANTHENE DERIVATIVE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS CEREUS; BACILLUS SUBTILIS; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; DRUG DESIGN; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MEDICINAL PLANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROMORPHOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PATHOGENESIS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; RHODOMYRTUS TOMENTOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS; TRADITIONAL MEDICINE;

ANTI-BACTERIAL AGENTS; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MYRTACEAE; XANTHONES;

BACILLUS CEREUS; BACILLUS SUBTILIS; ENTEROCOCCUS FAECALIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; RHODOMYRTUS TOMENTOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS;

EID: 67349154100     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.01.010     Document Type: Article

References (20)

1. Carson C.F., Mee B.J., and Riley T.V. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob. Agents Chemother. 46 (2002) 1914-1920
2. Chusri S., and Voravuthikunchai S.P. Quercus infectoria: a candidate for the control of methicillin-resistant Staphylococcus aureus infections. Phytother. Res. 22 (2008) 560-562
3. Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard. seventh ed (2006), Clinical and Laboratory Standards Institute Document M7-A7. Clinical and Laboratory Standards Institute, 900 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA
4. Horne D.S., Holm M., Oberg C., Chao S., and Young D.G. Antimicrobial effects of essential oils on Streptococcus pneumoniae. J. Essent. Oil Res. 13 (2001) 387-392
5. Latiff A.M. Rhodomyrtus tomentosa (Aiton) Hassk. In: Coronel R.E., and Verheij E.W.M. (Eds). Plant Resources of South-East Asia: Edible Fruits and Nuts (1992), Prosea Foundation, Indonesia 276-277
6. Mativandlela S.P., Meyer J.J., Hussein A.A., Houghton P.J., Hamilton C.J., and Lall N. Activity against Mycobacterium smegmatis and M. tuberculosis by extract of South African medicinal plants. Phytother. Res. 22 (2008) 841-845
7. Nazemiyeh H., Rahman M.M., Gibbons S., Nahar L., Delazar A., Ghahramani M.A., Talebpour A.H., and Sarker S.D. Assessment of the antibacterial activity of phenylethanoid glycosides from Phlomis lanceolata against multiple-drug-resistant strains of Staphylococcus aureus. Nat. Med. 62 (2008) 91-95
8. Ong H.C., and Nordiana M. Malay ethno-medico botany in Machang, Kelantan, Malaysia. Fitoterapia 70 (1999) 502-513
9. Oonmetta-aree J., Suzuki T., Gasaluck P., and Eumkeb G. Antimicrobial properties and action of galangal (Alpinia galanga Linn.) on Staphylococcus aureus. LWT 39 (2006) 1214-1220
10. Pankuch G.A., Jacobs M.R., and Appelbaum P.C. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40 (1996) 2071-2074
11. Pesewu G.A., Cutler R.R., and Humber D.P. Antibacterial activity of plants used in traditional medicines of Ghana with particular reference to MRSA. J. Ethnopharmacol. 116 (2008) 102-111
12. Salni D., Sargent M.V., Skelton B.W., Soediro I., Sutisna M., White A.H., and Yulinah E. Rhodomyrtone, an antibiotic from Rhodomyrtus tomentosa. Aus. J. Chem. 55 (2002) 229-232
13. Voravuthikunchai S.P., Limsuwan S., and Chusri S. New perspectives on herbal medicines for bacterial Infection: natural products II. In: Govil J.N., Singh V.K., and Siddqui N.T. (Eds). Recent Progress in Medicinal Plants (2007), Studium Press, USA 41-101
14. Wei F. Manufacture of oral liquid containing traditional Chinese medicine extract for treating gynecopathy (2006), (Guangxi Huahong Pharmaceutical Co., Ltd., Peop. Rep. China; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.), Faming Zhuanli Shenqing Gongkai Shuomingshu. China Patent No. CN1846715
15. Wei F. Manufacture of traditional Chinese medicine composition for treating urinary tract infection (2006), (Gungxi Huahong Pharmaceutical Co., Ltd., Peop. Rep. China; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.), Faming Zhuanli Shenqing Gongkai Shuomingshu. China Patent No. CN1853687
16. Winotai A., Wright T., and Goolsby J.A. Herbivores in Thailand on Rhodomyrtus tomentosa (Myrtaceae), an invasive weed in Florida. Fl. Entomol. 88 (2005) 104-105
17. World Health Organization (WHO), 2002a. WHO Traditional Medicine Strategy 2002-2005. 〈http://www.who.int/medicines/publications/traditionalpolicy/en/index.html〉.
18. World Health Organization (WHO). 2002b. Antimicrobial resistance, Fact Sheet No. 194, 〈http://www.who.int/mediacentre/factsheets/fs194/en/〉.
19. Reference for S. aureus SH1000: Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, et al., 2002. sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184, 5457-5467.
20. Reference for S. pneumonia D39: Lanie JA, et al., 2007. Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J Bacteriol 189, 38-51.